SCM
VNDA icon

Sterling Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Sterling Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Sell
1,846
-1,365
-43% -$10.5K ﹤0.01% 2250
2025
Q4 		$28.3K Sell
3,211
-633
-16% -$3.48K ﹤0.01% 2044
2025
Q3 		$19.2K Buy
3,844
+2,316
+152% +$10.7K ﹤0.01% 2168
2025
Q2 		$7.21K Buy
1,528
+544
+55% +$2.38K ﹤0.01% 2317
2025
Q1 		$4.52K Sell
984
-843
-46% -$3.93K ﹤0.01% 2218
2024
Q4 		$8.75K Buy
1,827
+1,646
+909% +$7.9K ﹤0.01% 2228
2024
Q3 		$849 Buy
+181
New +$970 ﹤0.01% 2624
2014
Q2 		– Sell
-10,589
Closed -$172K – 939
2014
Q1 		$172K Buy
+10,589
New +$151K ﹤0.01% 915

Other funds holding VNDA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return